1. Home
  2. OSUR vs THH Comparison

OSUR vs THH Comparison

Compare OSUR & THH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSUR
  • THH
  • Stock Information
  • Founded
  • OSUR 2000
  • THH 2013
  • Country
  • OSUR United States
  • THH Japan
  • Employees
  • OSUR N/A
  • THH N/A
  • Industry
  • OSUR Medical/Dental Instruments
  • THH
  • Sector
  • OSUR Health Care
  • THH
  • Exchange
  • OSUR Nasdaq
  • THH Nasdaq
  • Market Cap
  • OSUR 229.7M
  • THH 226.7M
  • IPO Year
  • OSUR 1986
  • THH 2025
  • Fundamental
  • Price
  • OSUR $3.25
  • THH $4.99
  • Analyst Decision
  • OSUR Hold
  • THH
  • Analyst Count
  • OSUR 1
  • THH 0
  • Target Price
  • OSUR $3.00
  • THH N/A
  • AVG Volume (30 Days)
  • OSUR 590.2K
  • THH 561.1K
  • Earning Date
  • OSUR 11-05-2025
  • THH 01-01-0001
  • Dividend Yield
  • OSUR N/A
  • THH N/A
  • EPS Growth
  • OSUR N/A
  • THH N/A
  • EPS
  • OSUR N/A
  • THH 0.02
  • Revenue
  • OSUR $138,533,000.00
  • THH $20,390,561.00
  • Revenue This Year
  • OSUR N/A
  • THH N/A
  • Revenue Next Year
  • OSUR $5.35
  • THH N/A
  • P/E Ratio
  • OSUR N/A
  • THH $294.84
  • Revenue Growth
  • OSUR N/A
  • THH 14.93
  • 52 Week Low
  • OSUR $2.36
  • THH $4.20
  • 52 Week High
  • OSUR $4.60
  • THH $12.00
  • Technical
  • Relative Strength Index (RSI)
  • OSUR 56.40
  • THH N/A
  • Support Level
  • OSUR $3.12
  • THH N/A
  • Resistance Level
  • OSUR $3.46
  • THH N/A
  • Average True Range (ATR)
  • OSUR 0.16
  • THH 0.00
  • MACD
  • OSUR 0.02
  • THH 0.00
  • Stochastic Oscillator
  • OSUR 62.82
  • THH 0.00

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a lifestyle entertainment company that operates in Japan offering a diverse range of services across the entertainment and hospitality sectors. Its principal businesses are (i)event curation ; (ii) consultancy and management services; (iii) sub-leasing of entertainment venues; and (iv) ownership and operation of restaurants. The company has four reportable segments: consultancy and management, event curation, sub-leasing and restaurant operation. The maximum of its revenue is derived from the consultancy and management segment.

Share on Social Networks: